Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.
J. Clin. Invest. P Yotnda, et al. 101:2290
doi:10.1172/JCI488 [Go to this article.]

Problems with a PDF?